Sponsors often face delays caused by fragmented communication between CROs and clinical sites.
Wakefield Clinical Research solves this challenge by operating as both a CRO and an active clinical research site, enabling more efficient study execution.
• Faster study startup
• Better coordination between study management and site operations
• Reduced operational cost
• Direct oversight of study conduct
• Direct access to experienced leadership
• Flexible operational support for early-stage biotech companies
Study Design & Protocol Development
Regulatory Strategy & IND Support
Project Management
Clinical Monitoring
Data Management & Biostatistics
Medical Writing & Regulatory Submissions
Wakefield Clinical Research operates an active clinical trial site supporting early-phase and specialty clinical studies.
Capabilities include:
• Phase I patient studies
• PK and drug-drug interaction studies
• Intensive PK sampling
• Experienced investigators and study coordinators
Oncology
Infectious disease
CNS/Neurology
Cardiovascular
Metabolic & Endocrine
Respiratory
Gastrointestinal
Dermatology
Ophthalmology
✔ Integrated CRO + Site Model
✔ Faster Study Startup
✔ Flexible Support for Biotech Sponsors
✔ Experienced Regulatory Strategy
✔ Direct Operational Oversight